{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:13:51Z","timestamp":1787030031286,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wacker Chemie AG, Munich, Germany"},{"name":"Free University Berlin"},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"crossref","award":["202206857010"],"award-info":[{"award-number":["202206857010"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Xenotransplantation using pig cells, tissues or organs may be associated with the transmission of porcine zoonotic or xenozoonotic microorganisms. Porcine endogenous retroviruses (PERVs) pose a special risk for xenotransplantation as these viruses can infect human cells and are integrated in multiple copies in the genome of all pigs and, therefore, they cannot be eliminated as other viruses can. To prevent PERV transmission to the recipient, several strategies have been developed: PERV-C-free animals, siRNA and genomic editing. Another strategy is the generation of vaccines based on neutralizing antibodies in order to protect the recipient. To investigate whether a protective vaccine is feasible in the case of PERV, the recombinant transmembrane (p15E) and the surface envelope (gp70) protein of PERV were cloned, produced, purified and used to immunize rats. For the first time, an adjuvant type that is approved for human use was used. In all cases we obtained virus binding antibodies as shown in Western blot assays and neutralizing antibodies as shown in neutralization assays, indicating the potential for a protective vaccine. The epitopes recognized by the antisera against p15E were determined using overlapping peptides. Two main epitopes were found in the sequence of p15E, one in the membrane proximal external region (MPER) and one in the fusion peptide proximal region (FPPR). The epitopes correspond to epitopes determined previously when immunizing different animal species with p15E of PERV. Antibodies against these epitopes block the conformational changes in the transmembrane envelope proteins that are required for membrane fusion, thereby inhibiting infection. The epitope in the MPER is related by sequence and location to an epitope in the transmembrane envelope protein of the human immunodeficiency virus-1 (HIV-1) recognized by a broadly neutralizing antibody from infected patients.<\/jats:p>","DOI":"10.3390\/v17111437","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:38:22Z","timestamp":1761759502000},"page":"1437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neutralizing Antibodies Against the Porcine Endogenous Retroviruses (PERVs)"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6752-0850","authenticated-orcid":false,"given":"Jinzhao","family":"Ban","sequence":"first","affiliation":[{"name":"Institute of Virology, Free University Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Krabben","sequence":"additional","affiliation":[{"name":"Institute of Virology, Free University Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-2695","authenticated-orcid":false,"given":"Benedikt B.","family":"Kaufer","sequence":"additional","affiliation":[{"name":"Institute of Virology, Free University Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3244-6085","authenticated-orcid":false,"given":"Joachim","family":"Denner","sequence":"additional","affiliation":[{"name":"Institute of Virology, Free University Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajt.2022.12.023","article-title":"Milestones on the path to clinical pig organ xenotransplantation","volume":"23","author":"Cooper","year":"2023","journal-title":"Am. J. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.3389\/ti.2024.13681","article-title":"What Genetic Modifications of Source Pigs Are Essential and Sufficient for Cell, Tissue, and Organ Xenotransplantation?","volume":"37","author":"Ali","year":"2024","journal-title":"Transpl. Int."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Denner, J. (2022). Virus Safety of Xenotransplantation. Viruses, 14.","DOI":"10.3390\/v14091926"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e12595","DOI":"10.1111\/xen.12595","article-title":"Prevention of infection in xenotransplantation: Designated pathogen-free swine in the safety equation","volume":"27","author":"Fishman","year":"2020","journal-title":"Xenotransplantation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41591-024-03429-1","article-title":"Transplantation of a genetically modified porcine heart into a live human","volume":"31","author":"Griffith","year":"2025","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1128\/JVI.72.12.9986-9991.1998","article-title":"Host range and interference studies of three classes of pig endogenous retrovirus","volume":"72","author":"Takeuchi","year":"1998","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/CMR.05011-11","article-title":"Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses","volume":"25","author":"Denner","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13880","DOI":"10.1128\/JVI.78.24.13880-13890.2004","article-title":"Evidence and consequence of porcine endogenous retrovirus recombination","volume":"78","author":"Bartosch","year":"2004","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12977-018-0411-8","article-title":"Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?","volume":"15","author":"Denner","year":"2018","journal-title":"Retrovirology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Fiebig, U., Kr\u00fcger, L., and Denner, J. (2024). Determination of the Copy Number of Porcine Endogenous Retroviruses (PERV) in Auckland Island Pigs Repeatedly Used for Clinical Xenotransplantation and Elimination of PERV-C. Microorganisms, 12.","DOI":"10.3390\/microorganisms12010098"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e12858","DOI":"10.1111\/xen.12858","article-title":"Genetic diversity, growth and heart function of Auckland Island pigs, a potential source for organ xenotransplantation","volume":"31","author":"Lange","year":"2024","journal-title":"Xenotransplantation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1399-3089.2008.00442.x","article-title":"Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs","volume":"15","author":"Dieckhoff","year":"2008","journal-title":"Xenotransplantation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1399-3089.2009.00525.x","article-title":"Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs","volume":"16","author":"Ramsoondar","year":"2009","journal-title":"Xenotransplantation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3089.2012.00683.x","article-title":"Long-term effects of PERV-specific RNA interference in transgenic pigs","volume":"19","author":"Semaan","year":"2012","journal-title":"Xenotransplantation"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Semaan, M., Ivanusic, D., and Denner, J. (2015). Cytotoxic Effects during Knock Out of Multiple Porcine Endogenous Retrovirus (PERV) Sequences in the Pig Genome by Zinc Finger Nucleases (ZFN). PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122059"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aad1191","article-title":"Genome-wide inactivation of porcine endogenous retroviruses (PERVs)","volume":"350","author":"Yang","year":"2015","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aan4187","article-title":"Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9","volume":"357","author":"Niu","year":"2017","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1099\/0022-1317-67-9-1901","article-title":"Immunoprevention of Friend leukaemia virus-induced erythroleukaemia by vaccination with aggregated gp70","volume":"67","author":"Kleiser","year":"1986","journal-title":"J. Gen. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Almeras, T., Schreiber, P., Fournel, S., Martin, V., Nicolas, C.S., Fontaine, C., Lesbros, C., and Gueguen, S. (2017). Comparative efficacy of the Leucofeligen\u2122 FeLV\/RCP and Purevax\u2122 RCP FeLV vaccines against infection with circulating feline Calicivirus. BMC Vet. Res., 13.","DOI":"10.1186\/s12917-017-1217-y"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0042-6822(02)00140-X","article-title":"Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: Basis for a vaccine for xenotransplantation?","volume":"307","author":"Fiebig","year":"2003","journal-title":"Virology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virol.2010.12.032","article-title":"Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs)","volume":"411","author":"Kaulitz","year":"2011","journal-title":"Virology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1743-422X-9-260","article-title":"Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs)","volume":"9","author":"Denner","year":"2012","journal-title":"Virol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/vir.0.047399-0","article-title":"Neutralization of porcine endogenous retrovirus by antibodies against the membrane-proximal external region of the transmembrane envelope protein","volume":"94","author":"Waechter","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12026-013-8430-y","article-title":"Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV)","volume":"58","author":"Waechter","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1385\/1-59259-083-7:211","article-title":"The adjuvant MF59: A 10-year perspective","volume":"Volume 42","year":"2000","journal-title":"Vaccine Adjuvants: Preparation Methods and Research Protocols, Methods in Molecular Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0264-410X(91)90262-5","article-title":"Genetically-engineered subunit vaccine against feline leukaemia virus: Protective immune response in cats","volume":"9","author":"Marciani","year":"1991","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2009.02.024","article-title":"A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR","volume":"159","author":"Behrendt","year":"2009","journal-title":"J. Virol. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0042-6822(03)00428-8","article-title":"Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells","volume":"314","author":"Denner","year":"2003","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"Zwick","year":"2001","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2567.2005.02291.x","article-title":"Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E","volume":"117","author":"Langhammer","year":"2006","journal-title":"Immunology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1128\/JVI.73.7.6089-6092.1999","article-title":"Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion","volume":"73","author":"Salzwedel","year":"1999","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JVI.73.3.2469-2480.1999","article-title":"A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity","volume":"73","author":"Salzwedel","year":"1999","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0264-410X(00)00267-X","article-title":"Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein","volume":"19","author":"Cussac","year":"2000","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1128\/jvi.68.5.3015-3026.1994","article-title":"Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities","volume":"68","author":"Earl","year":"1994","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1128\/jvi.68.6.4031-4034.1994","article-title":"Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS","volume":"68","author":"Muster","year":"1994","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/aid.2013.0191","article-title":"Immunization with hybrid proteins containing the membrane proximal external region of HIV-1","volume":"30","author":"Strasz","year":"2014","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gustchina, E., Li, M., Louis, J.M., Anderson, D.E., Lloyd, J., Frisch, C., Bewley, C.A., Gustchina, A., Wlodawer, A., and Clore, G.M. (2010). Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001182"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.0506927102","article-title":"A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope","volume":"102","author":"Miller","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sabin, C., Corti, D., Buzon, V., Seaman, M.S., Lutje Hulsik, D., Hinz, A., Vanzetta, F., Agatic, G., Silacci, C., and Mainetti, L. (2010). Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001195"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.antiviral.2010.11.011","article-title":"Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: Absence of antigenemia following challenge","volume":"89","author":"Langhammer","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000318892","article-title":"Increased neutralizing antibody response after simultaneous immunization with leucogen and the feline leukemia virus transmembrane protein","volume":"54","author":"Langhammer","year":"2011","journal-title":"Intervirology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:33:57Z","timestamp":1761888837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/11\/1437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["v17111437"],"URL":"https:\/\/doi.org\/10.3390\/v17111437","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}